1. Home
  2. INM vs PET Comparison

INM vs PET Comparison

Compare INM & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • PET
  • Stock Information
  • Founded
  • INM 1981
  • PET 2015
  • Country
  • INM Canada
  • PET United States
  • Employees
  • INM N/A
  • PET N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • PET EDP Services
  • Sector
  • INM Health Care
  • PET Technology
  • Exchange
  • INM Nasdaq
  • PET Nasdaq
  • Market Cap
  • INM 3.2M
  • PET 8.4M
  • IPO Year
  • INM N/A
  • PET N/A
  • Fundamental
  • Price
  • INM $2.35
  • PET $0.15
  • Analyst Decision
  • INM
  • PET Strong Buy
  • Analyst Count
  • INM 0
  • PET 5
  • Target Price
  • INM N/A
  • PET $4.90
  • AVG Volume (30 Days)
  • INM 46.2K
  • PET 11.3M
  • Earning Date
  • INM 05-20-2025
  • PET 05-12-2025
  • Dividend Yield
  • INM N/A
  • PET N/A
  • EPS Growth
  • INM N/A
  • PET N/A
  • EPS
  • INM N/A
  • PET N/A
  • Revenue
  • INM $4,832,013.00
  • PET $70,507,000.00
  • Revenue This Year
  • INM N/A
  • PET $7.87
  • Revenue Next Year
  • INM N/A
  • PET $122.23
  • P/E Ratio
  • INM N/A
  • PET N/A
  • Revenue Growth
  • INM N/A
  • PET N/A
  • 52 Week Low
  • INM $1.72
  • PET $0.08
  • 52 Week High
  • INM $15.70
  • PET $2.47
  • Technical
  • Relative Strength Index (RSI)
  • INM 36.01
  • PET 49.37
  • Support Level
  • INM $2.25
  • PET $0.14
  • Resistance Level
  • INM $3.20
  • PET $0.16
  • Average True Range (ATR)
  • INM 0.20
  • PET 0.03
  • MACD
  • INM -0.07
  • PET 0.01
  • Stochastic Oscillator
  • INM 10.00
  • PET 54.95

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About PET Wag! Group Co.

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.

Share on Social Networks: